Skip to content

Clinical trials

Phase 3 Osteoarthritis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoarthritis Phase: Phase 3 Country / region: Germany Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20033
20043
20051
20071
20094
20101
20151
20162
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis6
Grünenthal GmbH4
Pfizer4
Eli Lilly and Company2
Genzyme, a Sanofi Company2
Charite University, Berlin, Germany1
DePuy International1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoarthritis21
Pain5
Arthritis3
Osteoarthritis, Knee3
Chronic Pain2
Musculoskeletal Diseases2
Obesity2
Osteoarthritis, Hip2
Collagen Diseases1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.